On June 19, 2018, in FTC v. Boehringer Ingelheim Pharmaceuticals, Inc., the U.S. Court of Appeals for the D.C. Circuit affirmed the judgment of the DC District Court that documents prepared by Boehringer employees, that were requested by their general … Continue reading →